Welcome to our dedicated page for Odysight.ai SEC filings (Ticker: ODYS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Odysight.ai Inc. (NASDAQ: ODYS) SEC filings page on Stock Titan provides access to the company’s regulatory documents as filed with the U.S. Securities and Exchange Commission. Odysight.ai is a Nevada corporation whose common stock is listed on the Nasdaq Capital Market under the symbol ODYS, and its filings offer detailed information on its AI-powered visual sensing, Predictive Maintenance (PdM), and Condition-Based Monitoring (CBM) business.
Among the key filings are Form 10-K annual reports and related documents, which, as referenced in company press releases, discuss Odysight.ai’s operations, risk factors, and financial statements. Form 8-K current reports, such as those dated August 13, 2025 and November 13, 2025, furnish press releases announcing financial results and business updates, while other 8-K filings cover events like updated investor presentations and executive appointments.
Odysight.ai has also filed a Form S-1 registration statement related to the resale of common stock by selling stockholders, which describes the company’s business overview, corporate history, subsidiaries in Israel and Europe, and its focus on visual-based PdM and CBM solutions. A DEF 14A definitive proxy statement outlines matters for stockholder votes, including director elections, executive compensation advisory votes, share incentive plan amendments, and auditor ratification.
On Stock Titan, users can review these filings in one place and use AI-powered summaries to understand lengthy documents such as 10-Ks, S-1 registration statements, and proxy materials. The platform also surfaces real-time updates from EDGAR, making it easier to track new Odysight.ai filings, interpret financial and operational disclosures, and follow governance items presented to shareholders.
Odysight.ai Inc. proposes an at-the-market offering to sell up to $20,000,000 of common stock from time to time through Roth Capital Partners under a Sales Agreement dated June 5, 2026. Sales will be made at market prices and the Agent may act as agent or principal.
The prospectus supplement states proceeds may be used for research and development, sales and marketing, working capital and other general corporate purposes; the Agent’s compensation is up to 3.0% of gross proceeds. The company reports a public float of approximately $63.5 million based on 8,701,361 shares held by non-affiliates and a <$7.30> per-share reference, and confirms the Form S-3 resale limit tied to that public float.
Odysight.ai Inc. entered into a new Sales Agreement with Roth Capital Partners that allows it to sell up to $20,000,000 of common stock in at-the-market offerings. Shares may be sold from time to time at prevailing market prices or through privately negotiated transactions.
Roth Capital will act as sales agent and/or principal and can earn a commission of up to 3.0% of the gross proceeds on shares sold. Odysight.ai will reimburse up to $75,000 of initial expenses and up to $7,500 per quarter for ongoing expenses. Any shares sold will be issued under the company’s effective Form S-3 shelf registration.
Odysight.ai Inc. reported that its board, following a recommendation from the Compensation Committee, granted Chief Operating Officer Ronen Tanami an option to purchase 40,000 shares of common stock under the 2024 Stock Incentive Plan at an exercise price of $5.09 per share.
One-third of the option vests on the first anniversary of the grant date, with the remaining shares vesting over the following two years in eight equal quarterly installments, as long as Tanami remains a service provider. The option includes accelerated vesting if there is a change of control of the company.
Odysight.ai Inc. reported that Chief Operating Officer Tanami Ronen received a grant of 40,000 options to purchase common stock at an exercise price of $5.09 per share. One-third of the options vest on May 19, 2027, with the rest vesting quarterly over the following 24 months, becoming fully vested on May 19, 2029. After this award, Ronen holds 40,000 options directly, which expire on May 19, 2036. This is a compensation-related grant, not an open-market share purchase or sale.
Odysight.ai Inc. Chief Operating Officer Tanami Ronen reported initial beneficial ownership of stock options in a Form 3. These options give the right to buy 70,000 shares of common stock at an exercise price of $5.14 per share and expire on February 19, 2036. The options vest over three years, with one-third vesting on January 1, 2027 and the remaining two-thirds vesting in equal quarterly installments over the following two years, subject to continued service.
Odysight.ai Inc. reported weak results for the three months ended March 31, 2026, as revenue dropped to $82 thousand from $2.1 million a year earlier. Management attributes the decline mainly to prior-period contract derecognition and delayed purchase order execution amid geopolitical disruptions.
Gross profit was $21 thousand with a gross margin of about 26%, similar to last year, while operating expenses rose to roughly $5.4 million, reflecting expanded global sales and marketing. Net loss widened to approximately $5.2 million from $4.3 million. The company ended the quarter with about $21.8 million in cash and a backlog of $14 million, and it remains confident in its 2026 business targets.
Odysight.ai Inc. reported first-quarter 2026 revenue of $82,000, sharply lower than $2,065,000 a year earlier, mainly because Q1 2025 included one-time derecognition of a large medical contract liability and the company saw softer demand amid regional tensions with Iran.
The net loss widened to $5,181,000 from $4,265,000 as research and development and sales and marketing spending increased while general and administrative costs declined. Cash and cash equivalents were $21,763,000 as of March 31, 2026, and management believes this will fund operations for at least the next 12 months. Remaining performance obligations and backlog were about 14.0 million, reflecting contracted work not yet recognized as revenue.
Odysight.ai continues to focus on AI-driven visual monitoring solutions for predictive maintenance in industrial, automotive and aviation markets, and during the quarter it completed cashless exercise of legacy warrants, extended the life of certain employee stock options and prepared for an office move in Israel. Its common stock now trades on both the Nasdaq Capital Market and the Tel Aviv Stock Exchange under the symbol ODYS.
Odysight.ai Inc. Schedule 13G/A amendment reports beneficial ownership stakes held by a group of related Israeli reporting persons and investment entities. The filing lists Y.D. More Investments Ltd. as holding 973,543 shares (5.95%) and shows related entities and individuals with positions ranging from 0 to 973,543 shares.
The filing states More Provident holds 460,661 shares (2.82%), More Investment holds 512,882 shares (3.13%), and More Mutual holds 0 shares (0.00%). The securities are held for fund/portfolio beneficiaries; shared voting power is reported for several reporting persons.
Odysight.ai Inc. furnished an updated investor presentation on its website on April 10, 2026, and attached it as Exhibit 99.1 to this report. The presentation may be used in discussions with investors, analysts, and other third parties and is provided under Regulation FD as “furnished,” not “filed,” under the Exchange Act.
Odysight.ai Inc. is adding a dual listing for its common stock on the Tel Aviv Stock Exchange. The shares have been approved for listing, with trading on TASE expected to begin on April 9, 2026 under the ticker ODYS (also “אודס” in Hebrew).
The stock will continue to trade on the Nasdaq Capital Market while also being traded on TASE in Israeli Shekels. The company states that the dual listing is intended to broaden its investor base, enhance trading liquidity, improve accessibility for Israeli and international investors, and strengthen its presence in the Israeli capital market as part of its long-term global growth strategy.